British journal of clinical practice. Supplement (Br J Clin Pract Suppl)

Journal PubWeight™ 76.51‹?›

Top papers

Rank Title Year PubWeight™‹?›
151 Alpha-interferon in the treatment of malignant lymphoma. 1988 0.75
152 Effects of enoximone in patients with cardiac failure after myocardial infarction. 1988 0.75
153 Enoximone in heart failure: mechanisms of action. 1988 0.75
154 Review of central haemodynamic effects of alpha-blockers and their future use in hypertension. 1987 0.75
155 Basis of treatment of myocardial failure. 1988 0.75
156 The clinical pharmacology of dihydroergotoxine mesylate (Hydergine). 1985 0.75
157 Enoximone in intensive care. Proceedings of a symposium. Brussels, Belgium, 21st March 1988. 1988 0.75
158 First European review of terazosin. Proceedings of a symposium. Reykjavik, Iceland, 29th-31st May 1987. 1987 0.75
159 Interferon therapy--molecular mechanisms and clinical applications. Proceedings of a satellite symposium held at the 4th European Conference on Clinical Oncology and Cancer Nursing. Madrid, Spain, 1st-4th November 1987. 1988 0.75
160 Nosocomial gram-negative bacillary infections in compromised hosts: considerations on prevention and therapy. 1988 0.75
161 Comparison of Algicon and ranitidine in the therapy of reflux oesophagitis: preliminary results. 1989 0.75
162 Fat metabolism in the perioperative period. 1988 0.75
163 Changing requirements? The small bowel as a metabolic organ. 1988 0.75
164 Nedocromil sodium: a new therapeutic option for reversible obstructive airways disease. 1987 0.75
165 Some aspects of enteral feeding after abdominal surgery. 1988 0.75
166 Pre-operative feeding. 1988 0.75
167 Definitions and types of airflow limitation. 1987 0.75
168 Empiric antibiotic therapy in the neutropenic patient. 1988 0.75
169 Pre-operative intravenous nutrition. 1988 0.75
170 Risk factors for post-operative complications. 1988 0.75
171 Asthma: current treatment in perspective. 1987 0.75
172 Anxiety: the pharmacological and sociological interface. Proceedings of a symposium. Englefield Green, Surrey, 29 November-1 December, 1984. 1985 0.75
173 The economic and clinical consequences of childhood pyrexia. 1990 0.75
174 Supervised Antabuse therapy. 1984 0.75
175 The general practitioner's role in the detection of alcohol misuse in the community. 1984 0.75
176 Scientific rationale and clinical implications of sustained-release formulations. 1988 0.75
177 Difficulties in the classification of reversible obstructive airways disease. 1987 0.75
178 The neurological basis of anxiety. 1985 0.75
179 Buspirone: its potential role in the treatment of general practice anxiety. 1985 0.75
180 Models of anxiety. 1985 0.75
181 Syndromes of anxiety. 1985 0.75
182 The diagnosis of anxiety in primary care settings. 1985 0.75
183 Physical symptoms of anxiety. 1985 0.75
184 Anxiety in historical perspective. 1985 0.75
185 The non-pharmacological management of anxiety. 1985 0.75
186 The pharmacological treatment of anxiety. 1985 0.75
187 Anxiety, performance and anti-anxiety drugs. 1985 0.75
188 Neuropharmacological profile of buspirone: a non-benzodiazepine anxiolytic with specific mid-brain modulating properties. 1985 0.75
189 The psychological effects of buspirone. 1985 0.75
190 Clinical profile of buspirone. 1985 0.75
191 Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. 1988 0.75
192 Senile dementia and stroke--therapeutic possibilities. Proceedings of a symposium. Amsterdam, 6 December 1984. 1985 0.75
193 The effects of Hydergine on neurotransmitters. 1985 0.75
194 The ageing brain and dementia--a review. 1985 0.75
195 Pre-stroke and immediate post-stroke hypertension: neuroepidemiological data. 1985 0.75
196 Aspects of stroke trials. 1985 0.75
197 Event related evoked potentials in dementia. 1985 0.75
198 The early detection of dementia with particular reference to the memory clinic. 1985 0.75
199 Viral infections: epidemiology and significance. 1988 0.75
200 Side-effects after Antabuse--myths or reality? 1984 0.75
Next 50